Age specific differences in efficacy and safety for the CYD-tetravalent dengue vaccine

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

(2015)   LANCET

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

(2015) Sri Rezeki Hadinegoro et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America

(2015) Luis Villar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dengue vaccines at a crossroad

(2015) A. Wilder-Smith et al.   SCIENCE

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia

(2015) Ilaria Dorigatti et al.   VACCINE

Live virus vaccines based on a yellow fever vaccine backbone: Standardized template with key considerations for a risk/benefit assessment

(2015) Thomas P. Monath et al.   VACCINE

Dengue vaccines: dawning at last?

(2014) Annelies Wilder-Smith   LANCET

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

(2014) Maria Rosario Capeding et al.   LANCET

Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy

(2014) Bradford D. Gessner et al.   VACCINE

Epidemiological Trends of Dengue Disease in Thailand (2000–2011): A Systematic Literature Review

(2014) Kriengsak Limkittikul et al.   PLoS Neglected Tropical Diseases

A Shorter Time Interval Between First and Second Dengue Infections Is Associated With Protection From Clinical Illness in a School-based Cohort in Thailand

(2013) Kathryn B. Anderson et al.   JOURNAL OF INFECTIOUS DISEASES

Identifying protective dengue vaccines: Guide to mastering an empirical process

(2013) Scott B. Halstead   VACCINE

Epidemiological Trends of Dengue Disease in Brazil (2000–2010): A Systematic Literature Search and Analysis

(2013) Maria Glória Teixeira et al.   PLoS Neglected Tropical Diseases

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

(2012) Arunee Sabchareon et al.   LANCET

Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 years

(2012) Yee Sin Leo et al.   Human Vaccines & Immunotherapeutics

From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

(2011) Bruno Guy et al.   VACCINE